Use of antiarrhythmics and implantable cardioverter-defibrillators in congestive heart failure

As much as half of the mortality in patients with congestive heart failure (CHF) resulting from left ventricular systolic dysfunction is attributable to sudden cardiac death. Thus, the identification of risk and prevention of sudden death are important components of treating this population of patie...

Ausführliche Beschreibung